Crozer Chester Medical Center, Pennsylvania Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2004
NCT00555880
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Crozer Chester Medical Center, Pennsylvania, USA | Crozer-Keystone Health System

Active Ingredients

Drugs in Phase 4 Trials (3)

abaloparatide (tymlos) (1 trial)

denosumab (prolia) (1 trial)

midodrine (proamatine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypotension (Phase 4)

Hypotension, Orthostatic (Phase 4)

Osteoporosis (Phase 4)

Osteoporosis, Postmenopausal (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3